Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 3,418 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Routine Clear all

Conditions: COVID 19, Rehabilitation, Inpatient, Hospitalized
Interventions: Tele-exergaming Tablet; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acne, Premenstrual Syndrome
Interventions: Skincare Routine, MINDBODYSKIN Supplement; Other · Dietary Supplement
Lead sponsor: Clearstem Skincare; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Relapsing Forms of MS
Interventions: Diroximel Fumarate; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 18
States / cities: West Hollywood, California • Washington D.C., District of Columbia • Louisville, Kentucky + 15 more

Conditions: Chronic Pain, Neuropathic Pain, Failed Back Surgery Syndrome, Complex Regional Pain Syndromes
Interventions: HD Study Electrode; Device
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Albany, New York

Conditions: Asthma
Interventions: Albuterol and budesonide inhalation aerosol; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 1,511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 11
States / cities: North Hollywood, California • Walnut Creek, California • Louisville, Kentucky + 8 more

Conditions: Pneumonia, Methicillin-Resistant Staphylococcus Aureus
Interventions: Polymerase Chain Reaction (PCR); Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: High Risk for Postoperative Cardiovascular Events
Interventions: endothelial function testing; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 50 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer
Interventions: 30-second ECG using the Kardia Mobile, routine care; Diagnostic Test · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 65 Years to 90 Years
Enrollment: 494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Thyroid Nodule
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Ischemic Stroke
Interventions: Enhanced Stroke Education, Usual Stroke Education; Behavioral
Lead sponsor: Washington Regional Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Glioblastoma, Recurrent Glioblastoma, GBM
Interventions: SonoCloud-9 (SC9), Carboplatin, Lomustine, Temozolomide; Device · Drug
Lead sponsor: CarThera; Industry
Eligibility: 18 Years and older
Enrollment: 560 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 23
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 16 more

Conditions: Gestational Diabetes Mellitus, Hypertension in Pregnancy, Dysglycemia
Interventions: OB Provider Clinical Decision Support (CDS), Patient Education (OB Visit), Text messaging, Patient Outreach, Primary Care Provider Clinical Decision Support (CDS), Patient Education (Primary Care Visit); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Low Back Pain, Mechanical, Acute Pain
Interventions: Emergency Department Digital Pain Self-Management Intervention (EDPSI), Routine Discharge Care; Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Diabetic Polyneuropathy, Weight Loss
Interventions: Weight Achievement and Intensive Treatment (Why WAIT); Other
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Preterm Birth
Interventions: Enhanced Intravenous Nutrition, Standard Intravenous Nutrition; Other
Lead sponsor: University of Minnesota; Other
Eligibility: Up to 30 Weeks
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Topical Anesthesia
Interventions: Lidocaine, Placebo, Propofol; Drug
Lead sponsor: Bassett Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Cooperstown, New York

Conditions: Intellectual Disability, Developmental Disability, Axis I Diagnosis, Mental Illness, Covid19, Coronavirus
Interventions: Generic Best Practices, Tailored Best Practices; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Aging
Interventions: Strength training; Behavioral
Lead sponsor: Queens College, The City University of New York; Other
Eligibility: 65 Years and older
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Flushing, New York

Conditions: Diabetes Mellitus, Health Behavior, Diabetes Mellitus, Type 2, Group Meetings
Interventions: Personalized Health Planning Program Administration, Usual Care; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Graft Healing
Interventions: Full-Thickness Skin Graft Sizing; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Nonsmall Cell Lung Cancer, NSCLC
Interventions: NovoTTF-200T, Immune checkpoint inhibitors or docetaxel; Device · Drug
Lead sponsor: NovoCure GmbH; Industry
Eligibility: 22 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 73
States / cities: Birmingham, Alabama • Chandler, Arizona • Phoenix, Arizona + 59 more

Conditions: Shoulder Injuries, Shoulder Pain
Interventions: Active Rehabilitation Program (ARP), Nonspecific Passive Intervention (NPI); Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: GYN Disorders, Urologic Diseases
Interventions: NMB with rocuronium bromide; Drug
Lead sponsor: Rainer Lenhardt; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Chronic Renal Insufficiency
Interventions: Aerobic Exercise Training; Other
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Newark, Delaware

Search by objective public record fields.

Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients

An RCT Evaluating the Efficacy of a Skincare Routine and Acne Supplement on Improving Acne and Other Symptoms of PMS

Study of Diroximel Fumarate in the Real-World Setting

Intraoperative Neuromonitoring Recording With a Novel SCS Paddle

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Trial of MRSA Polymerase Chain Reaction for Pneumonia

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules

REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)

Emergency Department Digital Pain Self-Management Intervention to Improve Acute Low Back Pain Outcomes

Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy

Enhanced Nutrition for Preterm Infants

Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

Optimizing Strength Training in Older Adults

T2D Pilot Study for Patients With Uncontrolled Type 2 Diabetes

Full-Thickness Skin Graft Sizing and Scar Quality

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial

Does Depth of Neuromuscular Blockade (NMB) Affect Surgical Conditions in Obese Patients Undergoing Robotic Surgery

Exercise and Vascular Function in Chronic Kidney Disease